Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial. [electronic resource]
Producer: 20150527Description: 151 p. digitalISSN:- 1471-2415
- Adult
- Aged
- Aged, 80 and over
- Amides -- adverse effects
- Antihypertensive Agents -- adverse effects
- Benzalkonium Compounds -- adverse effects
- Bimatoprost
- Cloprostenol -- adverse effects
- Cross-Over Studies
- Double-Blind Method
- Female
- Glaucoma, Open-Angle -- drug therapy
- Humans
- Intraocular Pressure -- drug effects
- Male
- Middle Aged
- Ocular Hypertension -- drug therapy
- Ophthalmic Solutions
- Preservatives, Pharmaceutical -- adverse effects
- Prospective Studies
- Therapeutic Equivalency
- Tonometry, Ocular
- Travoprost
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.